Studies involving sample source:Leukemia cells
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000474 | Metabolomic testing of a putative MDH inhibitor (targeted) | Human | University of Florida |
| ST000475 | Metabolomic testing of a putative MDH inhibitor (global) | Human | University of Florida |
| ST001029 | An integrated, high-throughput strategy for multi-omic systems level analysis | Human | Vanderbilt University |
| ST003195 | Unveiling cellular changes in leukaemia cell line K-562 after cannabidiol treatment through lipidomics | Human | Universidad CEU San Pablo |
| ST003196 | Unveiling cellular changes in leukaemia cell line HL-60 after cannabidiol treatment through lipidomics | Human | Universidad CEU San Pablo |
| ST003819 | Polar metabolite profiling of SLC31A1 knockout cells compared to intergenic sgRNA containing cells | Human | Boston Childrens Hospital |
| ST003835 | metabolomics of wild-type and TauT-/- leukemia cells | Mouse | University of Rochester Medical Center |
| ST003836 | 13C taurine tracing in K562 human leukemia cells | Human | University of Rochester Medical Center |
| ST004099 | A genome-scale metabolic model for deciphering the host metabolic perturbations during Mycobacterium tuberculosis infection | Human | Translational health science and technology institute |
| ST004416 | Polar metabolite profiling of BCS-treated SEM cells with or without inosine and uridine supplementation | Human | Boston Childrens Hospital |
| ST004417 | Polar metabolite profiling of NALM6, REH, or MOLT16 cells treated with BCS or copper chloride. | Human | Boston Childrens Hospital |
| ST004418 | Polar metabolite profiling of BCS-treated NALM6, REH or MOLT16 cells with or without rescue with copper (II) chloride and 15N-amide-glutamine tracing | Human | Boston Children's Hospital |
